OT: BW in ANCOVA [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-06-18 13:39 (1157 d 21:16 ago) – Posting: # 20335
Views: 3,711

Hi ElMaestro,

» I believe they meant to do an ANCOVA with total dose as covariate.

So do I.

At the 2nd GBHI conference (Rockville 2016) body weight as a covariate was a hot topic. Body weight changes quite often in studies of anti-cancer drugs. The FDA was happy with that. No way for the EMA – as usual.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,305 posts in 4,668 threads, 1,587 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Friday 10:55 CEST (Europe/Vienna)

Doctors are men who prescribe medicines of which they know little,
to cure diseases of which they know less,
in human beings of whom they know nothing.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz